Browsing: Obesity

What does it mean to be obese if you feel healthy? BMI is only part of the answer. Asian risk thresholds and a proposed rethink of obesity explain why the label needs a closer look.

GLP-1 drugs may do more than suppress appetite. Early trials suggest semaglutide can reduce alcohol cravings and heavy drinking, although it remains an unproven addiction treatment.

Log In or Register as a healthcare professional to read the full article.

You can look slim and still carry dangerous visceral fat. This hidden belly fat surrounds vital organs and raises risks for heart disease, diabetes, and fatty liver disease.

Visceral fat is not just a metabolic problem. Research shows it fuels inflammation, speeds up brain ageing, and raises the risk of cognitive decline and dementia.

Struggling with belly fat after 40? Hormones, muscle loss, slower metabolism, stress and poor sleep can all reshape the midlife waistline. Here is why it happens and what you can realistically do.

Your heart, kidneys and metabolism are more connected than you think. When one fails, the others follow. Cardiovascular-Kidney-Metabolic (CKM) syndrome explains why prevention matters more than ever.

Obesity remains one of Singapore’s most neglected heart risk factors, despite its proven link to cardiovascular disease. With stigma and policy lagging behind science, experts argue for urgent, systemic change.

Novo Nordisk launches Wegovy in China, targeting the country’s 180 million people with obesity. Priced at ¥1,400 ($192 USD) per starter dose, it faces accessibility challenges as it’s not covered by national insurance. The move heightens competition with Eli Lilly.

From lifestyle changes and diet adjustments to medications and minimally invasive procedures, diverse weight loss options are available to help individuals achieve lasting health goals.